Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288

Showing 1-25 of 288 citing articles:

Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Jun Ren, Ne N. Wu, Shuyi Wang, et al.
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1745-1807
Open Access | Times Cited: 252
From Systemic Inflammation to Myocardial Fibrosis
Walter J. Paulus, Michael R. Zile
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1451-1467
Open Access | Times Cited: 218
Biomarkers of aging
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 197
Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
Anureet K. Shah, Sukhwinder K. Bhullar, Vijayan Elimban, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 931-931
Open Access | Times Cited: 118
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies
Kazunori Omote, Frederik H. Verbrugge, Barry A. Borlaug
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 321-337
Open Access | Times Cited: 111
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Jason D. Roh, Joseph A. Hill, Abhilasha Singh, et al.
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1906-1925
Open Access | Times Cited: 99
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
Julia Ritterhoff, Rong Tian
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 812-829
Closed Access | Times Cited: 92
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy – A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology
Marco Guazzi, Matthias Wilhelm, Martin Halle, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 8, pp. 1327-1345
Open Access | Times Cited: 83
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes
Bozhi Ye, Hao Zhou, Yanghao Chen, et al.
Circulation Research (2023) Vol. 132, Iss. 4, pp. 465-480
Open Access | Times Cited: 61
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Simon Kloock, Christian G. Ziegler, Ulrich Dischinger
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108549-108549
Open Access | Times Cited: 51
Hypertensive heart disease: risk factors, complications and mechanisms
Sepiso K. Masenga, Annet Kirabo
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 49
Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
Yu-Chen Wang, Yen Chin Koay, Calvin Pan, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 371-389
Open Access | Times Cited: 47
Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology
Tommaso Angelone, Carmine Rocca, Vincenzo Lionetti, et al.
Antioxidants and Redox Signaling (2024) Vol. 40, Iss. 7-9, pp. 369-432
Closed Access | Times Cited: 18
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
Alexander Fuerlinger, Alina Stockner, Simon Sedej, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
Izabela Tuleta, Nikolaos G. Frangogiannis
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113904-113904
Open Access | Times Cited: 87
Inflammation in Metabolic Cardiomyopathy
Florian A. Wenzl, Samuele Ambrosini, S A Mohammed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 69
Immunometabolic mechanisms of heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Pilar Alcaide, Gianluigi Condorelli, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 3, pp. 211-222
Open Access | Times Cited: 64
Chronic low‐grade inflammation in heart failure with preserved ejection fraction
Thássio Mesquita, Yen‐Nien Lin, Ahmed Ibrahim
Aging Cell (2021) Vol. 20, Iss. 9
Open Access | Times Cited: 58
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 15, pp. 3016-3051
Open Access | Times Cited: 55
Signaling cascades in the failing heart and emerging therapeutic strategies
Xin He, Tailai Du, Tianxin Long, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 50
SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes
Xiaoqian Wu, Huan Liu, Alan Brooks, et al.
Circulation Research (2022) Vol. 131, Iss. 11, pp. 926-943
Open Access | Times Cited: 46
Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction
Song Shen, Junfeng Duan, Jiaxin Hu, et al.
European Journal of Pharmacology (2022) Vol. 929, pp. 175126-175126
Open Access | Times Cited: 42
HMGB1‐Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice
Xinlin Zhang, Tingyu Wang, Zhen Chen, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 40
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction
Arjun Pandey, Deepak L. Bhatt, Avinash Pandey, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3640-3651
Closed Access | Times Cited: 37
Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456
Jingjing Wan, Zhen Zhang, Chennan Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top